Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain of tumor necrosis

Author:  ["Guo-Min Deng","Lixin Zheng","Francis Ka-Ming Chan","Michael Lenardo"]

Publication:  Nature Medicine

CITE.CC academic search helps you expand the influence of your papers.

Tags:     Medicine

Abstract

Tumor necrosis factor (TNF)-α has an important role in the pathogenesis of autoimmune and inflammatory diseases such as rheumatoid and septic arthritis. The biological effects of TNF-α are mediated by binding to TNF receptors TNFR1 (also known as P60) or TNFR2 (also known as P80). The pre-ligand assembly domain (PLAD) is a portion of the extracellular region of TNFRs that mediates receptor-chain association essential for signaling. We found that soluble versions of PLAD, especially those derived from P60, block the biochemical effects of TNF-α in vitro and potently inhibit arthritis in animal models. Thus, targeting the PLAD may have clinical value in the treatment of human arthritis and other disorders involving receptors of the TNFR superfamily.

Cite this article

Deng, GM., Zheng, L., Ka-Ming Chan, F. et al. Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain of tumor necrosis factor receptors. Nat Med 11, 1066–1072 (2005). https://doi.org/10.1038/nm1304

View full text

>> Full Text:   Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain of tumor necrosis

Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific

Cdk5-dependent regulation of glucose-stimulated insulin secretion